eHealthvsJP Morgan Chase & Co.

EHTH and JPM stock compared: price, dividend, valuation and results, from SEC filings.

eHealth (EHTH) has a market value of $12M and JP Morgan Chase & Co. (JPM) $912B. Over the last year, with dividends, EHTH moved -90.0% and JPM +13.5%. Dividend yield: EHTH none, JPM 1.82%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    EHTH$12M

    JPM$912B

    JPM is 76,936 times EHTH

  • Revenue, 12 months

    EHTH$469M

    JPM$203B

    JPM is 433 times EHTH

  • Net income, 12 months

    EHTH$23M

    JPM$66.0B

    JPM is 2,874 times EHTH

  • Operating margin

    EHTH10.6%

    JPM–

  • ROIC

    EHTH4.9%

    JPM15.1%

    10.2 points apart

  • P/E

    EHTH–

    JPM14.1

  • Dividend yield

    EHTH0.0%

    JPM1.8%

    1.8 points apart

  • 5-year return

    EHTH-98.6%

    JPM+129.9%

    228.5 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

EHTH-98.6%

JPM+129.9%

010020020222023202420252026
Returns by period
PeriodEHTHWith dividendsJPMWith dividends
1 year since November 14, 2025-90.0%Price -90.0%+13.5%Price +11.4%
3 years since November 16, 2023-95.0%-63.2% a yearPrice -95.0%+138.0%+33.5% a yearPrice +123.3%
5 years since November 15, 2021-98.6%-57.5% a yearPrice -98.6%+129.9%+18.1% a yearPrice +103.0%
10 years since November 16, 2016-96.1%-27.8% a yearPrice -96.1%+467.0%+18.9% a yearPrice +336.9%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

EHTHeHealthJPMJP Morgan Chase & Co.

Valuation

EHTHJPM
Valuation
Price$0.38$338.25
Market value$12M$912B
Enterprise value (EV)––
P/E–14.1
P/E, 5-year median–11.1
P/B0.02.6
EV/EBIT––
Free cash flow yield––

Results and growth

EHTHJPM
Results and growth
Revenue, 12 months$469M$203B
Net income, 12 months$23M$66.0B
Free cash flow, 12 months-$17M–
Earnings per share, 12 months-$0.89$23.85
Revenue growth, year on year4.1%2.8%
Revenue growth a year, past-1.0%over 5 years+8.8%over 5 years
EPS growth a year, past–+17.7%over 5 years

Margins and returns on capital

EHTHJPM
Margins and returns on capital
Gross margin44.7%–
Operating margin10.6%–
Net margin4.9%32.5%
ROIC4.9%15.1%
ROE4.2%18.0%

Balance sheet

EHTHJPM
Balance sheet
Cash$88M$1.11T
Total debt–$531B
Net debt / EBITDA––
Interest cover3.2×–

Dividends and buybacks

EHTHJPM
Dividends and buybacks
Dividend yield–1.8%
Dividend per share, 12 months–$6.15
Dividend growth a year, past–+10.0%over 5 years
Buyback yield–3.5%
Shareholder yield–5.3%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: EHTH or JPM

Didn't find what you were looking for?

Ask us
Which is bigger, eHealth or JP Morgan Chase & Co.?

By market value, JP Morgan Chase & Co. ($912B) is about 76,936.5 times eHealth ($12M), at today's prices.

How did EHTH and JPM stock do over the last 10 years?

Since November 16, 2016, EHTH's price moved -96.1% and JPM's +336.9%. With dividends: EHTH -96.1% (-27.8% a year), JPM +467.0% (+18.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, EHTH or JPM?

The dividend yield at today's price is none for eHealth and 1.82% for JP Morgan Chase & Co.. Over the last twelve months they paid – and $6.15 per share.

Which has the higher profit margins, eHealth or JP Morgan Chase & Co.?

Over the last twelve months, the net margin was 4.9% for eHealth and 32.5% for JP Morgan Chase & Co., and the operating margin 10.6% and –. Revenue was $469M and $203B.

Which is the better investment, eHealth or JP Morgan Chase & Co.?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.